How many institutions own ELTP stock?

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own ELTP shares is 1, representing N/A of the company's common stock.

Who are the major shareholders selling Elite Pharmaceuticals, Inc. stock?

ANCORA ADVISORS, LLC, in the last quarter, reduced its stake in ELTP by -100% restricting it's holding to 0 shares of worth nearly -. N/A also lessened N/A of the ELTP shares from its portfolio, reducing its holding to - shares of worth -. N/A also shunned ELTP shares holding by N/A last quarter which brought its holding to - shares worth -.

Investors who are buying ELTP stock?

As per its latest 13F filing, KELLEHER FINANCIAL ADVISORS increased its stake in ELTP by 100% in the last quarter. The institutional holder raised its holding to 1 thousand shares having worth more than $365.00. KELLEHER FINANCIAL ADVISORS also added 100% more shares of ELTP to its portfolio, raising its holding to 500 shares of worth $320.00. ANCORA ADVISORS, LLC also increased its ELTP shares holding by 100% which brought its holding to 5.18 thousand shares worth $2.25K.

ELTP's major insiders: who are they?

The insider with the most stakes in ELTP is EPIC PHARMA LLC , 10 percent owner at the company. Additionally, ELTP stock is highly held by 10 percent owner EPIC INVESTMENTS, LLC and Chief Scientific Officer NIGALAYE ASHOK G among others.

Did an insider recently sell ELTP stock?

Company executives, directors, and other insiders own 22.38% percent of Elite Pharmaceuticals, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which ELTP insiders have sold stock, totaling 0 shares. Insiders that have sold shares include PLASSCHE DOUGLAS, ELITE PHARMACEUTICALS INC /NV/, and TREPPEL JERRY.

Which insider recently purchased ELTP stock?

There have been 1 transaction(s) during the past 6-months in which Elite Pharmaceuticals, Inc. insiders have bought stock, totalling 30000 shares

How much of ELTP does insiders own?

Around 3.27M Elite Pharmaceuticals, Inc. shares are held by insiders, which represents about 22.38% of ELTP stock.

Who is the insider with the largest stake?

ELTP 10 percent owner, EPIC PHARMA LLC holds the largest portfolio of the company's shares. ELTP shares owned by EPIC total nearly 67.67 million.

Which institution holds the most shares in ELTP?

KELLEHER FINANCIAL ADVISORS is the largest institutional owner in ELTP which holds 1 thousand shares worth $365.00 or 0% of the total ELTP shares outstanding followed by KELLEHER FINANCIAL ADVISORS with ownership of 500 shares representing 0% of the ELTP ownership. KELLEHER FINANCIAL ADVISORS is the third largest stakeholder with 500 shares or 0% of the ownership worth more than $245.00.

Is Elite Pharmaceuticals, Inc. stock optionable?

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the ELTP is concerned, it is a stock which is not optionable.

Is there a short position on ELTP's shares?

Number of ELTP shares short is 757.07K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

About how many outstanding ELTP shares are there?

As of today, 1.02B shares of ELTP are outstanding.

Is there many float in ELTP stock?

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, ELTP has 845.24M shares in float.

ELTP short ratio: what is it?

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for ELTP is null.

Elite Pharmaceuticals (ELTP) insider trading activity: Get Latest News Today

Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableNo

OptionableNo

Short Percent Of Outstanding Shares2.16

Short Percent Of FloatN/A

Shares Outstanding1.02B

Shares Float845.24M

Shares Short757.07K

Short RatioN/A

N/A

Short % of Float

2.16%

Short % of Shares Outstanding

Market Insider

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

22.38% Percentage of Shares held by All Insiders

N/A Percentage of Shares held by All Institutions

N/A Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About N/A of ELTP shares are held by financial institutions. KELLEHER FINANCIAL ADVISORS is the top corporate investor, holding 1K shares valued at $365.00. A 0% stake in Elite Pharmaceuticals, Inc. is owned by the company. KELLEHER FINANCIAL ADVISORS owns 500 shares valued at $180.00, which translates its holding of 0% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Jun 30, 2026	KELLEHER FINANCIAL ADVISORS	0%	1K	365	500	+100.00%
Mar 31, 2026	KELLEHER FINANCIAL ADVISORS	0%	500	180	0	0
Dec 31, 2025	KELLEHER FINANCIAL ADVISORS	0%	500	245	0	0
Dec 31, 2025	ANCORA ADVISORS, LLC	0%	0	-	-5.18K	-100.00%
Sep 30, 2025	KELLEHER FINANCIAL ADVISORS	0%	500	320	500	+100.00%
Sep 30, 2025	ANCORA ADVISORS, LLC	0%	5.18K	3.32K	0	0
Jun 30, 2025	ANCORA ADVISORS, LLC	0%	5.18K	3.79K	0	0
Mar 31, 2025	ANCORA ADVISORS, LLC	0%	5.18K	2.25K	5.18K	+100.00%
Dec 31, 2023	FISHER ASSET MANAGEMENT, LLC	0.01%	82K	11.48K	0	0
Sep 30, 2023	FISHER ASSET MANAGEMENT, LLC	0.01%	82K	7.69K	82K	+100.00%

Insiders

Among the ELTP insiders holding of 22.38% of the stake in company, EPIC PHARMA LLC, 10 percent owner, holds the largest shares of 67.67M. EPIC INVESTMENTS, LLC, 10 percent owner, is the second largest ELTP insider with ownership of 67.67M shares. NIGALAYE ASHOK G, Chief Scientific Officer, stands third with possession of 20.3M shares of that stake.

Insiders	Designation	Shares Held
EPIC PHARMA LLC	10 percent owner	67.67M
EPIC INVESTMENTS, LLC	10 percent owner	67.67M
NIGALAYE ASHOK G	Chief Scientific Officer	20.3M
TREPPEL JERRY		7.64M
NARINE JEENARINE		5.51M
PLASSCHE DOUGLAS	EVP Operations	3.5M
DASH BARRY H	director	3.27M
HAKIM NASRAT A	CEO & President	2.7M
ELITE PHARMACEUTICALS INC /NV/	EVP Operations	1.8M
KIRKOV KIRKO	Chief Commercial Officer	16.37K

Buying/Selling by Insiders

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Aug 19, 2026	DASH BARRY H	PURCHASE	0.29	30K	8.61K	3.27M
Oct 02, 2025	PLASSCHE DOUGLAS	SALE	0.62	800K	499.2K	3.5M
Aug 22, 2025	ELITE PHARMACEUTICALS INC /NV/	SALE	0.52	500K	262.15K	1.8M
Jul 10, 2025	KIRKOV KIRKO	PURCHASE	0.59	16.37K	9.64K	16.37K
Jul 08, 2025	PLASSCHE DOUGLAS	SALE	0.58	200K	115.8K	2.3M
Oct 24, 2024	PLASSCHE DOUGLAS	SALE	0.51	333.93K	170.31K	0
Oct 23, 2024	PLASSCHE DOUGLAS	SALE	0.49	800K	392K	333.93K
Mar 18, 2016	TREPPEL JERRY	SALE	0.34	258.09K	88.27K	7.64M
Mar 17, 2016	TREPPEL JERRY	SALE	0.34	312.43K	107.79K	7.9M
Feb 24, 2016	TREPPEL JERRY	SALE	0.31	100.46K	31.14K	8.21M
Feb 22, 2016	TREPPEL JERRY	SALE	0.32	100K	32.09K	8.31M
Feb 17, 2016	TREPPEL JERRY	SALE	0.31	50K	15.58K	8.41M
Feb 05, 2016	TREPPEL JERRY	SALE	0.33	24.4K	8.05K	8.34M
Feb 04, 2016	TREPPEL JERRY	SALE	0.32	349.66K	111.89K	8.36M
Feb 03, 2016	TREPPEL JERRY	SALE	0.33	45.52K	15.02K	8.71M
Feb 02, 2016	TREPPEL JERRY	SALE	0.33	13K	4.29K	8.76M
Feb 01, 2016	TREPPEL JERRY	SALE	0.34	312.3K	106.18K	8.77M
Jan 29, 2016	TREPPEL JERRY	SALE	0.35	115K	40.25K	9.08M
Nov 18, 2015	TREPPEL JERRY	SALE	0.30	25K	7.63K	9.2M
Nov 17, 2015	TREPPEL JERRY	SALE	0.30	25K	7.5K	9.22M
Nov 16, 2015	TREPPEL JERRY	SALE	0.30	50K	15.13K	9.25M
Nov 13, 2015	TREPPEL JERRY	SALE	0.30	50K	15K	9.3M
Apr 27, 2015	PLASSCHE DOUGLAS	SALE	0.24	85.53K	20.17K	73.09K
Sep 26, 2014	HAKIM NASRAT A	PURCHASE	0.31	265.5K	82.38K	2.7M
Sep 25, 2014	HAKIM NASRAT A	PURCHASE	0.31	434.5K	133.96K	2.43M
May 09, 2014	NARINE JEENARINE	SALE	0.38	329.44K	125.94K	5.51M
Apr 02, 2014	NARINE JEENARINE	SALE	0.41	147.66K	60.54K	5.84M
Apr 01, 2014	NARINE JEENARINE	SALE	0.41	157.01K	64.63K	5.83M
Mar 27, 2014	NARINE JEENARINE	SALE	0.43	190.17K	81.17K	5.99M
Mar 11, 2014	NARINE JEENARINE	SALE	0.60	239.37K	144K	14.89M
Mar 11, 2014	NIGALAYE ASHOK G	SALE	0.60	239.37K	144K	20.3M
Mar 11, 2014	EPIC PHARMA LLC	SALE	0.60	239.37K	144K	67.67M
Mar 11, 2014	EPIC INVESTMENTS, LLC	SALE	0.60	239.37K	144K	67.67M
Mar 07, 2014	NARINE JEENARINE	SALE	0.68	1.05M	714.99K	14.94M
Mar 07, 2014	EPIC INVESTMENTS, LLC	SALE	0.68	1.05M	714.99K	67.91M
Mar 07, 2014	NIGALAYE ASHOK G	SALE	0.68	1.05M	714.99K	20.37M
Mar 07, 2014	EPIC PHARMA LLC	SALE	0.68	1.05M	714.99K	67.91M
Mar 06, 2014	EPIC PHARMA LLC	SALE	0.90	773.05K	692.34K	68.96M
Mar 06, 2014	NIGALAYE ASHOK G	SALE	0.90	773.05K	692.34K	20.69M
Mar 06, 2014	EPIC INVESTMENTS, LLC	SALE	0.90	773.05K	692.34K	68.96M
Mar 06, 2014	NARINE JEENARINE	SALE	0.90	773.05K	692.34K	15.17M
Jan 13, 2014	EPIC INVESTMENTS, LLC	SALE	0.18	805.54K	147.41K	69.73M
Jan 13, 2014	NIGALAYE ASHOK G	SALE	0.18	805.58K	147.42K	20.92M
Jan 13, 2014	EPIC PHARMA LLC	SALE	0.18	805.58K	147.42K	69.73M
Jan 13, 2014	NARINE JEENARINE	SALE	0.18	805.58K	147.42K	15.34M
Dec 05, 2013	EPIC PHARMA LLC	SALE	0.13	275K	34.51K	71M
Dec 05, 2013	NARINE JEENARINE	SALE	0.13	275K	34.51K	15.62M
Dec 05, 2013	NIGALAYE ASHOK G	SALE	0.13	275K	34.51K	21.3M
Dec 05, 2013	EPIC INVESTMENTS, LLC	SALE	0.13	275K	34.51K	71M
Dec 02, 2013	EPIC PHARMA LLC	SALE	0.13	100K	12.52K	71.3M
Dec 02, 2013	NIGALAYE ASHOK G	SALE	0.13	100K	12.52K	21.39M
Dec 02, 2013	EPIC INVESTMENTS, LLC	SALE	0.13	100K	12.52K	71.3M
Nov 27, 2013	NARINE JEENARINE	SALE	0.12	25K	3.03K	15.71M
Nov 27, 2013	EPIC PHARMA LLC	SALE	0.12	25K	3.03K	71.4M
Nov 27, 2013	EPIC INVESTMENTS, LLC	SALE	0.12	25K	3.03K	71.4M
Nov 27, 2013	NIGALAYE ASHOK G	SALE	0.12	25K	3.03K	21.42M
Nov 26, 2013	EPIC INVESTMENTS, LLC	SALE	0.12	357K	43.13K	71.43M
Nov 26, 2013	EPIC PHARMA LLC	SALE	0.12	357K	43.13K	71.43M
Nov 26, 2013	NIGALAYE ASHOK G	SALE	0.12	357K	43.13K	21.43M
Nov 26, 2013	NARINE JEENARINE	SALE	0.12	357K	43.13K	15.71M
Nov 19, 2013	NARINE JEENARINE	SALE	0.12	21K	2.5K	15.8M
Nov 19, 2013	EPIC INVESTMENTS, LLC	SALE	0.12	21K	2.46K	71.82M
Nov 19, 2013	NIGALAYE ASHOK G	SALE	0.12	21K	2.46K	21.55M
Nov 19, 2013	EPIC PHARMA LLC	SALE	0.12	21K	2.46K	71.82M
Nov 18, 2013	EPIC INVESTMENTS, LLC	SALE	0.12	1.17M	137.48K	71.85M
Nov 18, 2013	EPIC PHARMA LLC	SALE	0.12	1.17M	137.48K	71.85M
Nov 18, 2013	NIGALAYE ASHOK G	SALE	0.12	1.17M	137.48K	21.55M
Nov 18, 2013	NARINE JEENARINE	SALE	0.12	1.17M	137.48K	15.81M
Nov 15, 2013	NARINE JEENARINE	SALE	0.12	318.05K	37.31K	16.06M
Nov 15, 2013	EPIC PHARMA LLC	SALE	0.12	318.05K	37.31K	73.02M
Nov 15, 2013	NIGALAYE ASHOK G	SALE	0.12	318.05K	37.31K	24.1M
Nov 15, 2013	EPIC INVESTMENTS, LLC	SALE	0.12	318.05K	37.31K	73.02M
Nov 14, 2013	NARINE JEENARINE	SALE	0.12	465.09K	53.58K	16.13M
Nov 14, 2013	NIGALAYE ASHOK G	SALE	0.12	465.09K	53.58K	24.2M
Nov 14, 2013	EPIC INVESTMENTS, LLC	SALE	0.12	465.09K	53.58K	73.33M
Nov 14, 2013	EPIC PHARMA LLC	SALE	0.12	465.09K	53.58K	73.33M
Nov 11, 2013	EPIC PHARMA LLC	SALE	0.12	39K	4.78K	71.79M
Nov 11, 2013	NIGALAYE ASHOK G	SALE	0.12	39K	4.78K	21.54M
Nov 11, 2013	NARINE JEENARINE	SALE	0.12	39K	4.78K	15.79M
Nov 11, 2013	EPIC INVESTMENTS, LLC	SALE	0.12	39K	4.78K	71.79M
Nov 06, 2013	EPIC PHARMA LLC	SALE	0.12	122.2K	15.09K	73.8M
Nov 06, 2013	NIGALAYE ASHOK G	SALE	0.12	122.2K	15.09K	22.14M
Nov 06, 2013	NARINE JEENARINE	SALE	0.12	122.2K	15.09K	16.24M
Nov 06, 2013	EPIC INVESTMENTS, LLC	SALE	0.12	122.2K	15.09K	73.8M
Oct 29, 2013	EPIC INVESTMENTS, LLC	SALE	0.13	466K	59.18K	73.92M
Oct 29, 2013	NARINE JEENARINE	SALE	0.01	102.52K	1.3K	16.26M
Oct 29, 2013	EPIC PHARMA LLC	SALE	0.13	466K	59.18K	73.92M
Oct 29, 2013	NIGALAYE ASHOK G	SALE	0.13	139.8K	17.75K	22.18M
Oct 28, 2013	NARINE JEENARINE	SALE	0.13	102.3K	13.25K	16.37M
Oct 28, 2013	EPIC INVESTMENTS, LLC	SALE	0.13	465K	60.22K	74.39M
Oct 28, 2013	NIGALAYE ASHOK G	SALE	0.13	139.5K	18.07K	22.32M
Oct 28, 2013	EPIC PHARMA LLC	SALE	0.13	465K	60.22K	74.39M
Jan 03, 2013	EPIC PHARMA LLC	SALE	0.15	531.19K	79.68K	70.54M
Jan 03, 2013	EPIC INVESTMENTS, LLC	SALE	0.15	531.19K	79.68K	70.54M
Jan 03, 2013	NIGALAYE ASHOK G	SALE	0.15	531.19K	79.68K	21.16M
Jan 03, 2013	NARINE JEENARINE	SALE	0.15	531.19K	79.68K	15.52M

Insider Transaction Summary (6 Months)

SHARESTRANS

PURCHASE30K1

SALES00

NET SHARES30K1

SHARES HELD3.27M1

% NET SHARES-99.08%0%

ELTP Stock Ownership Breakdown